Skip to main content
OSUR logo

OSUR · Orasure Technologies Inc

$4.02 +0.06 (+1.52%) At close · Jul 28
Market Cap
$276.77M
Shares
68.85M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.02 Open$3.96 Day$3.93–4.04 52W$2.08–4.58 Avg vol 30d509K Short int3.3M · 4.7% float · 9.0d Short vol59% Last earningsMay 6, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 8

Up next

Next earnings call
Aug 5, 2026 Est · unconfirmed · in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 8, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 18.2 · elevated Equity put/call 0.71
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg +30%
      above
      Price vs 50-day avg −1%
      below
      RSI (14) 48
      neutral
      MACD trend Negative
      52-week position 78%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Strong
      1-month return −11%
      trailing
      6-month return +41%
      trailing
      YTD return +66%
      this year
      Relative strength +33%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $4 › 200d $3 — 50d above 200d
      Institutional flow Accumulating
      23 of 141 funds reported for Jun 30 · net +96.4K sh shares · +4 new
      Insider flow Accumulating
      Net +$224.8K over 90 days · 0% sells
      Short interest Rising
      4.74% of float · ▲ +9.8% MoM · 9.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      141 holders — near 3-yr low, contrarian setup
      Squeeze score 71
      high risk · 0–100
      Fundamentals
      Strong
      Revenue growth +30%
      Y/Y
      Gross margin 29%
      contracting
      EPS growth −262%
      Y/Y
      Free cash flow $-53.2M
      Buyback $40.0M
      authorized
      Balance sheet $192.0M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 49%
      annualized · 1-yr
      Max drawdown −39%
      past year
      ATR 4.6%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed May 6, 2026
      Total revenues · Q2 2026 Initiated $27M – $30M
      prior qtr $27.93M midpoint +2.1% QoQ
      Guided vs delivered · last 1 settled
      International Diagnostics business revenue full year 2025
      guided $30M – $35M
      $115.02M Beat +253.9%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 5 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +30% Bullish
      Price vs 50-day avg
      −1% Neutral
      RSI (14)
      48 Neutral
      MACD trend
      Negative Bearish
      52-week position
      78% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $4 › 200d $3 — 50d above 200d
      Institutional flow Accumulating
      23 of 141 funds reported for Jun 30 · net +96.4K sh shares · +4 new
      Insider flow Accumulating
      Net +$224.8K over 90 days · 0% sells
      Short interest Rising
      4.74% of float · ▲ +9.8% MoM · 9.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      141 holders — near 3-yr low, contrarian setup
      Price context
      position in its 52-week range
      52-wk low $2 Now $4 · 78% 52-wk high $5
      vs 200-day avg +30% vs 50-day avg -1%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Versus peers

      Medical Instruments & Supplies — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      OSUR
      Orasure Technologies Inc
      this stock
      $276.77M +66.1% +30.3% 4.7%
      ISRG
      Intuitive Surgical Inc
      $126.06B -36.1% +20.5% 41.0 1.9%
      MDLN
      Medline Inc.
      $53.22B -3.5% +11.5% 2.2%
      BDX
      Becton Dickinson & Co
      $43.79B +10.5% +8.2% 60.4 3.8%
      ALC
      Alcon Inc
      $33.70B -12.3% +10.5% 2.7%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      141
      % held
      82.0%
      Reported
      23 of 141
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      158
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      3.3M
      Days to cover
      9.0d
      Change
      +292.2K sh
      View
      Short Volume
      Short vol %
      59%
      As of
      Jul 28, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      1.1K
      Value
      $5.0K
      As of
      Jun 30, 2026
      View
      Off-Exchange
      Off-exchange %
      40.7%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$224.8K
      Buyers / Sellers
      1 / 0
      Buyers Sellers
      View
      Congressional Trades Sell
      Member
      Tom Malinowski
      Amount
      $15.0K–$50.0K
      Traded
      Feb 23, 2021
      View
      Financials
      Financials
      Revenue (FY)
      $115.0M
      Net income (FY)
      $-68.7M
      EPS diluted
      $-0.94
      View
      Buybacks
      Authorized
      $40.0M
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 11, 2026
      This year
      11
      View
      Proposed Sales
      Value
      $225.0K
      Shares
      89.7K
      Filed
      Dec 4, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      May 6, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      OSUR +5.8% -10.7% +40.6% -9.9% +66.1%
      SPY -1.0% 0.0% +7.4% -0.8% +8.6%
      vs SPY +6.8% -10.7% +33.1% -9.1% +57.5%

      Capital returns

      Buyback program · as of Jun 30, 2025
      Authorized
      $40.00M
      Spent (derived)
      Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1116463 CUSIP 68554V108 13F (30d) 23 filings 21 filers Visit website